Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 6/20 | 0.63 |
| ▸ | PTGER3 | P43115 | 6/20 | 0.63 |
| ▸ | PTGER1 | P34995 | 5/20 | 0.63 |
| ▸ | PTGER2 | P43116 | 5/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.55 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28313950 | 0.95 | PTGER1 (0.61) | PTGER4PTGER3PTGER1PTGER2HDAC3 | |
| SCHEMBL28959383 | 0.93 | PTGER1 (0.59) | PTGER4PTGER3PTGER1PTGER2HDAC3 | |
| SCHEMBL28417410 | 0.93 | PTGER1 (0.59) | PTGER4PTGER3PTGER1PTGER2HDAC3 | |
| SCHEMBL11069817 | 0.93 | PTGER1 (0.59) | PTGER4PTGER3PTGER1PTGER2HDAC3 | |
| SCHEMBL16178552 | 0.93 | PTGER1 (0.59) | PTGER4PTGER3PTGER1PTGER2HDAC3 | |
| Bromide SCHEMBL27464773 | 0.91 | PTGER1 (0.58) | PTGER4PTGER3PTGER1PTGER2HDAC3 | |
| SCHEMBL1261128 | 0.89 | PTGER4 (0.77) | PTGER4PTGER3PTGER1PTGER2FFAR4 | |
| SCHEMBL31212507 | 0.89 | PTGER4 (0.77) | PTGER4PTGER3PTGER1PTGER2FFAR4 | |
| SCHEMBL6053663 | 0.87 | PTGER4 (0.81) | PTGER4PTGER3PTGER1PTGER2FFAR4 | |
| SCHEMBL8479912 | 0.87 | PTGER4 (0.70) | PTGER4PTGER3PTGER1PTGER2FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1354740-A | Pharmaceutical compounds | NICOX SA (FR) | 2002-06-19 | — | — | CN | claimed |
| CN-119857095-A | Choroidal neovascularization inhibitor or drusen inhibitor and its evaluation or screening method | 林科杰诺米克斯股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-114716544-B | Complement component C5 antibodies | 阿勒根公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118251208-A | Degradable intrauterine system for prolonged release of active ingredient in uterine cavity | 沃梅德公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-111630154-B | Enhancing fibroblast regeneration activity | 菲格内有限责任公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-115996686-B | Medical device comprising expandable muscle polymer | 巴德外周血管股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-112041294-B | Co-crystals of panthenol and compositions comprising said co-crystals | 晶体工程智能研究中心 | 2024-02-20 | — | — | CN | disclosed |
| CN-110582286-B | Ocular application of matrix-bound vesicles (MBVs) | 联邦高等教育系统匹兹堡大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-115996686-A | Medical device comprising expandable muscle polymer | 巴德外周血管股份有限公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-114716544-A | Complement component C5 antibody | 阿勒根公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20040176393-A1 | Statin-MMP inhibitor combinations | NEWTON ROGER SCHOFIELD (US) | 2004-09-09 | — | — | US | disclosed |
| EP-1189882-A1 | BIPHENYL BUTYRIC ACID DERIVATIVE AS A MATRIX METALLOPROTEINASE INHIBITOR | SAMSUNG ELECTRONICS Co. Ltd. (KR) | 2002-03-27 | — | — | EP | disclosed |
| WO-2001083445-A1 | BIPHENYL BUTYRIC ACID DERIVATIVE AS A MATRIX METALLOPROTEINASE INHIBITOR | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2001-11-08 | — | — | WO | disclosed |
| WO-1995029892-A1 | HYDROXAMIC ACID AND AMINO ACID DERIVATIVES AND THEIR USE AS ANTI-ARTHRITIC AGENTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-11-09 | — | — | WO | disclosed |
| EP-0470832-B1 | Biphenyl 5,5'-bis-alkanoic acid derivatives, their production and use thereof | ASAHI CHEMICAL IND (JP) | 1994-12-14 | — | — | EP | disclosed |
| US-5326495-A | Tetrasubstituted methanes having liquid-crystalline properties | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 1994-07-05 | — | — | US | disclosed |
| US-5155259-A | High stability; prevention and therapy of diabetic complications | TOYO JOZO KABUSHIKI KAISHA (JP) | 1992-10-13 | — | — | US | disclosed |
| US-5136090-A | Antidiabetic agents | TOYO JOZO KABUSHIKI KAISHA (JP) | 1992-08-04 | — | — | US | disclosed |
| EP-0470832-A2 | Biphenyl 5,5'-bis-alkanoic acid derivatives, their production and use thereof | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1992-02-12 | — | — | EP | disclosed |
| US-3966801-A | ANTIINFLAMMATORY AGENTS | WILLIAM H. RORER, INC. (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176393-A1 | Statin-MMP inhibitor combinations | MMP9, TIMP3, MMP3 | PTGER4 340/4885PTGER3 203/4885PTGER1 144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.